Enrollment goal of 75 patient for the mild to moderate was obtained on 6/11. However I remember a statement that we would cease enrollment today on 6/15.
Is CytoDyn able to increase enrollment until today to increase the power of the study or are they only authorized to enroll 75 patients for the study by the FDA?